Narrative review / 2024
A review summarizes diagnosis and management options for shrimp allergy, which affects up to 2% of the US population.
Shrimp allergy is the most common food allergy in the United States, affecting up to 2% of the population. Currently, the double-blind, placebo-controlled food challenge serves as the gold standard for diagnosis. Mainstream and experimental management approaches include food allergen avoidance, FDA-approved omalizumab, and oral immunotherapy. The authors highlight an urgent need for more effective diagnostic tools and therapies.
- Study type
- Narrative review
- Who was studied
- People with shrimp allergy in the United States
- What was measured
- Diagnostic and management strategies for shrimp allergy
THE PAPER
Diagnosis and management of shrimp allergy.
Su BB, Blackmon W, Xu C, Holt C, Boateng N, Wang D, Szafron V, Anagnostou A, Anvari S, Davis CM. Front Allergy, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.